A detailed history of Bleakley Financial Group, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 9,899 shares of EWTX stock, worth $264,303. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,899
Previous 15,265 35.15%
Holding current value
$264,303
Previous $275 Million 3.9%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$15.88 - $29.5 $85,212 - $158,297
-5,366 Reduced 35.15%
9,899 $264 Million
Q2 2024

Aug 12, 2024

BUY
$15.08 - $21.23 $230,196 - $324,075
15,265 New
15,265 $275 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.69B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.